|
|
Volumn 64, Issue 22, 2007, Pages 2364-2372
|
|
Implications of the specialty drug marketplace for health-system pharmacy: A roundtable discussion
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
IMMUNOGLOBULIN;
INFLIXIMAB;
PROSTACYCLIN;
RECOMBINANT ERYTHROPOIETIN;
CLINICAL PHARMACY;
CONFERENCE PAPER;
DRUG COST;
DRUG MARKETING;
HEALTH CARE;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH CARE NEED;
HEALTH CARE UTILIZATION;
HEALTH INSURANCE;
HEALTH SERVICE;
HOSPITAL ORGANIZATION;
HOSPITAL PHARMACY;
HUMAN;
MEDICAL EDUCATION;
MEDICAL PRACTICE;
PHARMACEUTICAL CARE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
|
|
EID: 36448941451
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/ajhp070262 Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (2)
|
